Response to "Integrating pretreatment MRI-detected nodal features and Epstein-Barr virus DNA to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma".

, ,

Oral oncology Vol. 149 : 106674 • Feb 2024

No abstract available for this paper

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.

PICO extraction requires an abstract.

PMID: 38154446

DOI: 10.1016/j.oraloncology.2023.106674 [doi]

Publication Year: 2024

Language: e, n, g

No associated datasets or code repositories found for this paper.

Related paper suggestions will be available in future updates.